1302
S. Buchler et al. ■Novel Dinucleating Ligand Systems
(%) = 627 (100) [M++l], 514(78) [M+-CF3 CH2 NHCH2],
360 (54) [M+-N[(CH2 )2 NHCH2CF3]2],
C 8H ,|F 6N302 (295.2)
Calcd C 32.6 H 3.8 N 14.2%,
Found C 32.0 H 3.9 N 13.6%.
C2 |H3 4Fi2 N8 (626.5)
lb: yield (6.4 g, 19.8 mmol, 99%). 'H NMR (D6 -ace-
tone): b = 1.54 (s, 1H, NH), 1.77 (quint., VHh = 6.2 Hz,
4H, CH2), 2.76 (t, Vhh = 6.2 Hz, 4H, CH2), 3.48 (t, VHH=
6.2 Hz, 4H, CH2), 8.22 (s, 2H, NH). 13C{1H} NMR (D6-
acetone): 6 = 27.6 (CH2), 38.9 (CH2), 47.6 (CH2), 116.0
(q, '/c f = 286 Hz, CF3), 157.0 (q, 2JCf = 36 Hz, CO). I9F
NMR (D6 -acetone): b =-77.9. MS (EI) m/z (%) = 323 (10)
[M++l], 183 (87) [M+-CF3 CONHCH2CH2], 154 (100)
[CF3 CONH(CH2)3+], 126(100) [CF3 CONHCH2+].
Calcd C 40.3 H 5.5 N 17.9%,
Found C 40.3 H 6.0 N 17.8%.
Ligand H 5 L 4: Starting from pyrazole-3,5-dicarboxylic
acid monohydrate (2,7 g, 15.5 mmol) and lb (10.0 g,
31.0 mmol) the amide 2b (23.0 g, 30.0 mmol) was pre-
pared as described for 2a. 'H NMR (D6 -acetone): b =
1.94 (quint,V = 6.0 Hz, 8 H, CH2), 3.40 (t, V = 6.0 Hz,
8 H, CH2), 3.62, 3.81 (2t, V = 6.0 Hz, 8 H, E-/Z-CH2),
6.99 (s, 1H, pz-H4), 8.60 (s, 4H, NH). 13C{'H} NMR
(D6 -acetone): b = 25.9 (CH2), 37.6 (CH2), 43.9 (CH2),
Ci0 H15F6 N3 O2 (323.2)
46.7 (CH2), 108.9 (pz-C4), 116.9 (q, ' y C F
=
286Hz, CF3),
Calcd C 37.2 H 4.7 N 13.0%,
Found C 36.5 H 4.5 N 12.2%.
143.1 (pz-C3/5), 158.0 (q, 2/ Cf = 30 Hz, COCF3), 162.9
(CO). ,9F NMR (D6 -acetone): b = -77.3. MS (FAB+):
m/z (%) = 767 (100) [M++l], The reduction was car-
ried out analogously to the synthesis of H5L3 to yield
H5L4 (9.5 g, 15.0 mmol). IR (film): z>max/cirT 1 = 3271 (s),
2937(s), 2839(s), 1566(w), 1469(w), 1366(w), 1267(s),
1146(s), 952(m), 827(m), 664(m). 'H NMR (CDC13): b =
1.61 (quint,3/ = 6.5 Hz, 8 H, CH2), 2.45 (t, V = 6.5 Hz,
8 H, CH2), 2.70 (t, V = 6.5 Hz, 8 H, CH2), 3.10 (q, V Hf =
9.4 Hz, 8 H, CH2 CF3), 3.54 (s, 4H, CH2), 5.95 (s, 1H,
pz-H4). I3 C{'H} NMR (CDC13): b = 47.6 (CH2), 47.8
(CH2), 49.9 (CH2), 50.0 (q, 2JCf = 31 Hz, CH2CF3), 51.5
(CH2), 103.5 (pz-C4), 125.2 (q, ‘/ Cf = 277 Hz, CF3). I9F
NMR (CDC13): b = -72.2. MS (FAB+): m/z (%) = 683
(100) [M++l],
Ligand H 5 L 3 : Pyrazole-3,5-dicarboxylic acid mono-
hydrate (2.0 g, 11.5 mmol) was converted into 3,5-bis-
(chloroformyl)pyrazole by the usual reaction with thionyl
chloride (100 cm3). It was taken up in THF (100 ml) and
treated dropwise with a solution of la (7.1 g, 24.0 mmol)
and triethylamine (6 . 6 g, 92 mmol) in THF (100 ml). Af-
ter stirring overnight, a saturated aqueous sodium chlo-
ride solution was added. The phases were separated and
the THF phase was dried over MgS04 and filtered. THF
was removed under vacuum, the oily residue was taken
up in THF and filtered again. After evaporation of the
solvent the product 2 a remained as a yellow solid, 'H
NMR (06-acetone): 6 = 3.62 (t, V = 5.4 Hz, 8 H, CH2),
3.65, 4.00 (2t, V = 5.4 Hz, 8 H, E-/Z-CH2), 7.05 (s, 1H,
pz-H4), 8.81 (s, 4H, NH). 13C{'H} NMR (D6 -acetone):
b = 45.8 (CH2), 46.2 (CH2), 47.7 (CH2), 109.1 (pz-C4),
116.5 (q, '7cf = 285 Hz, CF3), 142.4 (pz-C3/5), 157.5 (q,
2JCf = 36 Hz, COCF3), 163.2 (CO). 19F NMR (D6 -ace-
C2 5 H42N8 FI2 (682.6)
Calcd C 44.0 H 6.2 N 16.4%,
Found C 43.6 H 6.5 N 15.6%.
Ligand H 5 L 5 : Starting from pyrazole-3,5-dicarboxylic
tone): b =-77.7. MS (FAB+) m/z (%) = 711 (62) [M++l ], acid monohydrate (1.3 g, 7.8 mmol) and lc [15b] (6.7 g,
416 (100) [M+-N[(CH2 )2 NHCOCF3]2. A solution of this
compound 2a (8 .1 g, 11.0 mmol) in THF was added drop-
wise to a suspension of LiAlH4 (1.9 g, 5.0 mmol) in THF
at room temperature. The mixture was heated to reflux
for 4 h, stirred overnight and hydrolysed by the drop-
wise addition of water. The precipitate was filtered off
and washed several times with THF. The combined or-
ganic phases were dried over MgS04 and evaporated to
15.5 mmol) the amide 2c (7.5 g, 7.6 mmol) was prepared
as described for 2a. 'H NMR (D6 -acetone): b = 3.65 (t,
2J = 5.4 Hz, 8 H, CH2), 3.65, 3.91 (2t, V = 5.4 Hz, 8 H, E-
/Z-CH2), 4.51 (s, 4H, NH), 7.10 (s, lH,pz-H4). I3 C{'H}
NMR (D6 -acetone): b = 44.6 (CH2), 47.8 (CH2), 49.7
(CH2), 109.5 (pz-C4), 125.1, 130.7,136.5,141.0(m,Car),
163.1 (CO). I9F NMR (D6 -acetone): 6 = -174.0,-168.0,
-162.0. MS (FAB+) m/z (%) = 991 (16) [M++ 1], 436 (100)
dryness to yield H5 L3 (6.7 g, 10.7 mmol) as a yellow- {NH[CH2CH2 NH(C6 F5)]2++ 1}. The reduction of 2c was
ish oil. IR (film): iW c m - 1 = 3289(s), 2937(s), 2837(s), carried out under the same conditions as above to yield
1566(w), 1454(w), 1351(w), 1268(s), 1161(s), 947(m), H5L5 (6.0 g, 7.4 mmol, 97 %). IR (film): //max/cm_l =
821(m),661(m).1H NMR (CDC13): <5= 1. 8 6 (s, 4H, NH), 3355 (s), 2941/2842 (vs), 1642 (w), 1606 (s), 1516 (s),
1359 (s), 1275/1183 (vs), 1107 (m), 1037 (s), 814 (m), 784
(m), 627 (m). 1H NMR (CDC13): b = 2.85 (t, V = 5.6 Hz,
2.59 (t, V = 5.3 Hz, 8 H, CH2), 2.75 (t, V = 5.3 Hz, CH2),
3.09 (q, V h f = 9.4 Hz, CH2CF3), 3.63 (s, 4H, CH2), 5.95
(s, 1H, pz-H4). 13C{1H} NMR (CDC13): 6 = 46.6 (CH2), 8 H, CH2), 3.10 (t, 3y = 5.6 Hz, 8 H, CH2), 3.72 (s, 4H,
CH2), 5.98 - 6.14 (m, 9H, pz-H4 and Har). i3 C{'H} NMR
(CDC13): b =41.4 (CH2), 50.2 (CH2), 53.9 (CH2). 95.8 (m,
48.5 (CH2), 50.0 (q, 2/ Cf = 31 Hz, CH2CF3), 53.6 (CH2),
102.9 (pz-C4), 125.3 (q, ' / c = 277 Hz, CF3), pz-C3 / 5 not
f
observed. ,9F NMR (CDC13): b = -72.2. MS (FAB+): m/z Car), 104.5 (pz-C4), 129.8, 135.1, 149.3, 154.1 (m, Car).
Brought to you by | New York University Bobst Library Technical Services
Authenticated
Download Date | 9/19/15 2:26 AM